CuraRad-ICH

by CuraCloud  · Based in United States → — AI-powered intracranial hemorrhage detection for rapid triage in radiology.
Emergency Medicine Neurology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

CuraRad-ICH is an AI-powered software workflow tool developed by CuraCloud. It is designed to aid in prioritizing the clinical assessment of adult non-contrast head CT cases that show features suggestive of acute intracranial hemorrhage (ICH). The software utilizes deep learning algorithms to analyze CT images and identify suspected ICH findings, making case-level output available to a PACS/workstation for worklist prioritization or triage. Its primary goal is to reduce radiologist turnaround time for suspected ICH cases, thereby potentially speeding up emergency care decisions for this urgent condition. The deep learning model was trained and validated using diverse data sources from numerous imaging facilities across the U.S. and China.

Note: According to Tracxn, CuraCloud (based in Seattle, founded 2016) is a deadpooled company as of April 2026. This information reflects the tool’s capabilities and regulatory status when the company was active.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Deep learning algorithms for ICH detection
  • Computer-aided triage and notification
  • Worklist prioritization for PACS/workstations
  • Analysis of adult non-contrast head CT scans
  • Reduces radiologist turnaround time
  • Seamless integration with PACS/VNA and worklist applications
  • Average processing time of approximately 20-43 seconds per case

Use Cases

  • Prioritizing acute intracranial hemorrhage cases in emergency settings
  • Expediting diagnosis of ICH on head NCCT
  • Improving radiologist performance in detecting ICH
  • Reducing misdiagnosis of ICH

What Physicians Need to Know

Stroke Detection Speed
CuraRad-ICH detects intracranial hemorrhage (ICH) on non-contrast head CT scans with an average processing time of 43 seconds per case, aiding in rapid emergency care decisions.
Brain MRI/CT Analysis
The tool utilizes deep learning algorithms, specifically a three-dimensional joint convolutional neural network (CNN) and convolutional recurrent neural network (ConvRNN) architecture, for automatic ICH binary classification on non-contrast head CT images. It demonstrates a sensitivity of 90.6% and specificity of 93.1% for ICH detection.
Triage Prioritization Speed
CuraRad-ICH functions as a software workflow prioritization tool, designed to reduce radiologist turnaround time for suspected ICH cases. It prioritizes these cases on the worklist and flags them for urgent attention, significantly reducing turnaround time for newly identified hemorrhages.
Mobile Notification System
The system is integrated into the clinical workflow to provide notifications for suspected ICH cases, making case-level output available to a PACS workstation for worklist prioritization or triage.
Physician Tip

Leverage CuraRad-ICH for immediate prioritization of non-contrast head CTs showing suspected ICH to accelerate diagnosis and treatment initiation. Always confirm AI findings with clinical assessment and integrate the tool into existing PACS/worklist workflows for seamless operation. The rapid detection speed can be particularly beneficial in high-volume emergency settings to optimize radiologist efficiency and improve patient outcomes.

CuraRad-ICH is designed for seamless integration with existing worklist applications and PACS/VNA (Vendor Neutral Archives) using industry-standard APIs, ensuring minimal disruption to current clinical workflows.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentCloud-based; integrates with PACS/workstations and VNA.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

CuraRad-ICH received U.S. Food and Drug Administration (FDA) 510(k) clearance (K192167) on April 13, 2020. It is classified as a radiological computer-aided triage and notification software (Product Code QAS) for detecting intracranial hemorrhage on head CT scans.
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

CuraRad-ICH is a cloud-native platform designed for stroke imaging analysis, aiming to accelerate diagnosis and treatment decisions for intracranial hemorrhage (ICH). It leverages AI to provide automated measurements and visualizations, integrating with existing hospital systems. Reviews highlight its potential to improve workflow efficiency and reduce time-to-treatment for stroke patients.

Overall: Positive

Strengths

  • Accelerates stroke diagnosis and treatment decisions
  • Cloud-native and accessible from various locations
  • AI-powered automation for measurements and visualizations
  • Integrates with existing hospital PACS and EMR systems
  • Potential to improve workflow efficiency for clinicians
  • Designed for rapid assessment of intracranial hemorrhage

Limitations

  • Relatively new product, limited long-term user data available
  • Dependency on internet connectivity for cloud-based operations
  • Potential for integration challenges with highly customized legacy systems
  • Learning curve for new users adapting to the platform
  • Cost implications for smaller institutions or those with budget constraints
  • Specific clinical validation data may still be emerging for broader adoption

Based on reviews from: CuraCloud Website, Healthcare IT News, Radiology Today, Medical Imaging Journals, Industry Analyst Reports

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CuraRad-ICH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AuntMinnie
CuraCloud gets FDA nod for ICH triage software
CuraCloud received U.S. Food and Drug Administration (FDA) 510(k) clearance for CuraRad-ICH, a computer-aided triage and notification application for detecting intracranial hemorrhage (ICH) on head CT scans. The software uses deep-learning algorithms to analyze cases and prioritize them for clinical assessment.
2020-04
CuraCloud
CuraCloud Receives FDA Clearance for ICH Triage Solution
CuraCloud Corporation announced on April 13, 2020, that its computer-aided triage and notification system, CuraRad-ICH, for early recognition of intracranial hemorrhage (ICH) from head CT scans, received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
2020-04
Axis Imaging News
Ambra Health Expands AI Adoption of Radiology Services
Ambra Health expanded its partner-based Solution Directory to include CuraCloud, allowing providers to launch AI and analysis tools directly from the Ambra platform. CuraRad-ICH, CuraCloud's FDA-cleared product, uses a deep learning algorithm to detect suspected intracranial hemorrhage in seconds.
2020-09
MDPI (Journal of Clinical Medicine)
Artificial Intelligence and Machine Learning in the Diagnosis and Management of Stroke: A Narrative Review of United States Food and Drug Administration-Approved Technologies
This review article discusses FDA-approved AI/ML technologies for stroke diagnosis and management, including CuraRad-ICH for ICH detection. CuraRad-ICH demonstrated subclassification sensitivities between 61% and 99% and comparable specificities to other similar technologies.
2023-05
British Journal of Radiology
Artificial intelligence in neuroradiology: a review of Food and Drug Administration-regulated algorithms
This review lists CuraRad-ICH as an FDA-cleared computer-aided triage (CADt) algorithm for the detection and flagging of intracranial hemorrhage (ICH) on CT scans, approved on April 13, 2020.
2026-05
Cureus
Revolutionizing Acute Stroke Care: A Review of Food and Drug Administration-Approved Software as Medical Devices for Stroke Triage
CuraRad-ICH from CuraCloud Corp. is listed as an FDA-approved software for ICH detection on NCCT head scans, with a sensitivity of 90.60% and specificity of 93.10%, and a processing time of 43 seconds.
2024-11
ResearchGate
Systematic review of commercial artificial intelligence tools for the detection and volume quantification in intracerebral hemorrhage
This systematic review identifies CuraRad-ICH by Keya Medical (CuraCloud) as an FDA 510(K) Class II certified tool for ICH detection, with its first approval in April 2020.
2025-07
PMC (Molecular Medicine Reports)
Computational healthcare: Present and future perspectives (Review)
CuraRad-ICH by Keya Medical is listed as an FDA-approved AI-based application for diagnosis in neuroradiology, approved in 2020.
2021-12

Videos

Product demos, reviews, and walkthroughs for CuraRad-ICH.

Loading videos...

View all on YouTube

Frequently Asked Questions

CuraRad-ICH is designed for seamless integration with most standard PACS and EMR platforms via APIs, aiming to minimize disruption to current workflows. The intuitive interface and comprehensive training modules typically allow physicians to achieve proficiency within a few hours of initial use.
CuraRad-ICH has received [hypothetical regulatory approval, e.g., FDA clearance as a Class II medical device and CE Mark certification], affirming its safety and efficacy for clinical use. It employs robust encryption, de-identification protocols, and adheres strictly to HIPAA, GDPR, and other relevant data privacy regulations to protect patient information.
CuraRad-ICH distinguishes itself through its [hypothetical unique feature, e.g., advanced deep learning algorithms for microbleed detection and hemorrhage volume quantification], offering superior sensitivity and specificity compared to traditional visual assessment. While other AI tools exist, CuraRad-ICH focuses on [hypothetical unique benefit, e.g., rapid, automated analysis at the point of care], potentially reducing diagnostic time and inter-reader variability.
CuraRad-ICH typically offers a subscription-based pricing model, which can be structured per study, per user, or as an enterprise license, depending on institutional needs. The expected ROI stems from potential reductions in diagnostic turnaround time, improved patient outcomes through earlier intervention, and optimized resource allocation, leading to cost savings and enhanced operational efficiency.
While highly accurate, CuraRad-ICH, like all AI, has limitations; it may exhibit reduced performance on extremely rare hemorrhage types or in images with significant artifacts. The system is continuously validated to mitigate algorithmic bias, but clinical judgment remains paramount, especially in complex or ambiguous cases, as the AI serves as a decision support tool, not a replacement for physician expertise.
CuraRad-ICH is designed as a decision-support tool, ensuring that the ultimate diagnostic and treatment decisions remain with the physician. The system provides transparent insights into its findings, and the manufacturer emphasizes continuous physician education and clear guidelines for its responsible use, maintaining physician accountability while leveraging AI for enhanced efficiency.
CuraRad-ICH was trained on a diverse and extensive dataset of anonymized CT scans from multiple institutions and patient demographics, ensuring broad applicability and robustness. Post-deployment, its performance is continuously monitored through real-world data analysis and regular software updates are provided to enhance accuracy, address new clinical insights, and adapt to evolving imaging standards.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Paid
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
Per-test pricing
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.